These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23430200)

  • 1. Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.
    Thompson DA; Lyons RJ; Russell-Eggitt I; Liasis A; Jägle H; Grünewald S
    J Inherit Metab Dis; 2013 Nov; 36(6):1039-47. PubMed ID: 23430200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal on-pathway deficit in congenital disorder of glycosylation due to phosphomannomutase deficiency.
    Thompson DA; Lyons RJ; Liasis A; Russell-Eggitt I; Jägle H; Grünewald S
    Arch Ophthalmol; 2012 Jun; 130(6):712-9. PubMed ID: 22801829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation.
    Barone R; Carrozzi M; Parini R; Battini R; Martinelli D; Elia M; Spada M; Lilliu F; Ciana G; Burlina A; Leuzzi V; Leoni M; Sturiale L; Matthijs G; Jaeken J; Di Rocco M; Garozzo D; Fiumara A
    J Neurol; 2015 Jan; 262(1):154-64. PubMed ID: 25355454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
    Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
    Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and whole-exome sequencing findings in two siblings from Hani ethnic minority with congenital glycosylation disorders.
    Zhang Z; Huang TL; Ma J; He WJ; Gu H
    BMC Med Genet; 2019 Nov; 20(1):181. PubMed ID: 31727010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies.
    Chong M; Yoon G; Susan-Resiga D; Chamberland A; Cheillan D; Paré G; Seidah NG
    J Med Genet; 2020 Jan; 57(1):11-17. PubMed ID: 31391289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation.
    De Graef D; Ligezka AN; Rezents J; Mazza GL; Preston G; Schwartz K; Krzysciak W; Lam C; Edmondson AC; Johnsen C; Kozicz T; Morava E
    Mol Genet Metab; 2023 Jun; 139(2):107606. PubMed ID: 37224763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Analysis of Variants in the General Population Reveals That
    Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.
    Monin ML; Mignot C; De Lonlay P; Héron B; Masurel A; Mathieu-Dramard M; Lenaerts C; Thauvin C; Gérard M; Roze E; Jacquette A; Charles P; de Baracé C; Drouin-Garraud V; Khau Van Kien P; Cormier-Daire V; Mayer M; Ogier H; Brice A; Seta N; Héron D
    Orphanet J Rare Dis; 2014 Dec; 9():207. PubMed ID: 25497157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From gestalt to gene: early predictive dysmorphic features of PMM2-CDG.
    Martinez-Monseny A; Cuadras D; Bolasell M; Muchart J; Arjona C; Borregan M; Algrabli A; Montero R; Artuch R; Velázquez-Fragua R; Macaya A; Pérez-Cerdá C; Pérez-Dueñas B; Pérez B; Serrano M;
    J Med Genet; 2019 Apr; 56(4):236-245. PubMed ID: 30464053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three families with mild PMM2-CDG and normal cognitive development.
    Vals MA; Morava E; Teeäär K; Zordania R; Pajusalu S; Lefeber DJ; Õunap K
    Am J Med Genet A; 2017 Jun; 173(6):1620-1624. PubMed ID: 28425223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.
    Zemet R; Hope KD; Edmondson AC; Shah R; Patino M; Yesso AM; Berger JH; Sarafoglou K; Larson A; Lam C; Morava E; Scaglia F
    Mol Genet Metab; 2024 Aug; 142(4):108513. PubMed ID: 38917675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.
    Serrano M; de Diego V; Muchart J; Cuadras D; Felipe A; Macaya A; Velázquez R; Poo MP; Fons C; O'Callaghan MM; García-Cazorla A; Boix C; Robles B; Carratalá F; Girós M; Briones P; Gort L; Artuch R; Pérez-Cerdá C; Jaeken J; Pérez B; Pérez-Dueñas B
    Orphanet J Rare Dis; 2015 Oct; 10():138. PubMed ID: 26502900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic manifestations of congenital disorder of glycosylation type 1a.
    Jensen H; Kjaergaard S; Klie F; Moller HU
    Ophthalmic Genet; 2003 Jun; 24(2):81-8. PubMed ID: 12789572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe.
    Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PMM2-CDG: phenotype and genotype in four affected family members.
    Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
    Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements.
    Coorg R; Lotze TE
    Neurology; 2012 Oct; 79(15):e131-3. PubMed ID: 23045520
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary ovarian insufficiency in a female with phosphomannomutase-2 gene (PMM2) mutations for congenital disorder of glycosylation.
    Masunaga Y; Mochizuki M; Kadoya M; Wada Y; Okamoto N; Fukami M; Kato F; Saitsu H; Ogata T
    Endocr J; 2021 May; 68(5):605-611. PubMed ID: 33583911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.